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Abstract
This review describes recent selected HPLC/MS methods for the determination of urinary 
mercapturates that are useful as non-invasive biomarkers in characterizing human exposure to 
electrophilic industrial chemicals in occupational and environmental studies. High performance 
liquid chromatography/mass spectrometry is a sensitive and specific method for analysis of small 
molecules found in biological fluids. In this review, recent selected mercapturate quantification 
methods are summarized and specific cases are presented. The biological formation of 
mercapturates is introduced and their use indicators of metabolic processing of reactive toxicants 
is discussed, as well as future trends and limitations in this area of research.
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Introduction
The measurement of urinary mercapturic acids (mercapturates) is important in 
characterizing human exposure to occupational and environmental toxicants. Toxicant 
concentrations found in the surrounding environment often do not correlate to an 
individual’s internal dose. Estimates based on models may not be accurate due to variations 
in toxicant absorption and metabolism in exposed individuals (De Rooij et al., 1998). 
Determination of urinary mercapturates, which are the products of toxicant metabolism, 
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provide useful biomarkers of individual toxicant absorption and internal dose (Vanwelie et 
al., 1992). The use of mercapturates as biomarkers of toxic occupational and environmental 
exposure has been extensively reviewed (De Rooij et al., 1998; Vanwelie et al., 1992) and a 
survey of HPLC separation and mass spectrometry techniques to quantitate these biomarkers 
has been undertaken in this review.
Mercapturate formation begins when glutathione (GSH), an endogenous tripeptide, reacts to 
inactivate an electrophilic toxicant or reactive toxicant metabolite either spontaneously or by 
catalysis with glutathione transferase in the liver and in other organs (Figure 1). Next 
glutamyl and glycine moieties are enzymatically removed to form a cysteine conjugate. This 
conjugate is, in turn, N-acetylated to form what is generally a toxicant-specific mercapturate 
(Perbellini et al., 2002). The initial reaction between endogenous GSH and an electrophilic 
moiety on a compound is considered as a detoxification step, and prevents reaction of the 
electrophilic metabolite with cellular components such as proteins, lipids or DNA. The final 
N-acetylation reaction increases the polarity and hydrophilicity of the metabolite, making it 
more water soluble and allowing for urinary excretion and elimination (De Rooij et al., 
1998; Vanwelie et al., 1992).
Mercapturate formation from a reactive toxicant is often complex and formation of multiple 
mercapturate products is possible. Urinary mercapturate determination provides a non-
invasive tool to investigate up-stream toxicant activation. Generally, investigations of 
toxicant metabolism are more easily done in experimental animals. However, differences in 
toxicant metabolism between species, especially those between the rodents generally used 
and that of humans are often significant. Identification and quantification of the 
mercapturate products of reactive metabolites can demonstrate differences in toxicant 
activation and detoxification between species. An understanding of these differences in 
toxicant activation is necessary for accurate risk analysis, especially when data from human 
volunteer or occupational studies are limited.
In the interest of brevity, the mercapturate names shown in Table 1 and used throughout this 
review are truncated from the systematic name of the S-conjugated electrophilic group 
except in the cases of acrylamide and the triazine and chloroacetamide herbicide derived 
mercapturates. Thus the systematic name for the mercapturate of benzene, N-acetyl-S-
(phenyl)-L-cysteine is shortened to phenyl mercapturate. The names and abbreviations used 
for mercapturates vary throughout the current literature, and are generally derived from the 
S-conjugated electrophilic group. The abbreviations used in this review, as they appear in the 
cited methods, are listed in Table 1 by parent compound.
This review describes selected HPLC-MS methods for determination of mercapturates as 
biomarkers of human exposure to industrial chemicals for use in occupational and 
environmental studies. Mercapturates are the detoxification products of a wide range of 
heterogenous electrophilic compounds (Table 1) and no single analytical approach for 
development of a method for a new specific mercapturate can be recommended. 
Alternatively, this work is a survey of the multiple analytical approaches described in 
recently published HPLC/MS mercapturate determinations.
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The current review focuses on HPLC/MS determination of a broad range of mercapturates. 
In 2002, Perbellini reviewed methods for determining mercapturates in biological exposure 
monitoring. The scope of that review included gas chromatographic (GC), and high-
performance liquid chromatographic (HPLC) methods, and it was limited to single 
mercapturates of benzene, toluene and xylene, and the detection of two of the mercapturate 
products of 1,3-butadiene and of trimethylbenzene (Perbellini et al., 2002). In this review, 
selected representative mercapturate methods are summarized in tabular format and 
highlights of the sample preparation and chromatography techniques used in these methods 
are briefly described. An overview of mercapturates as useful indicators of toxicant 
metabolism is presented. Mercapturates as specific indicators of toxicant exposure, 
metabolic activation and as tools to investigate toxicant metabolism and elimination are 
considered.
Tabular summaries of selected methods
Tables 2 and 3 summarize selected HPLC-MS methods reported for the detection and 
quantification of various mercapturates used in occupational and environmental studies. The 
terminology and abbreviations appearing in these tables indicate sample preparation 
techniques, chromatographic conditions, and mass spectrometry detection modes reported 
for these methods, and are explained in more detail in the following sections of this review.
Sample preparation techniques
Successful determination of mercapturates by HPLC/MS requires separation of analyte 
mercapturates from interfering components found in urine. Proteins, numerous metabolites, 
salts and other components that make up the urinary sample matrix interfere with the 
sensitive and specific detection of the target mercapturates. Salts may alter the intensity of 
the analyte signal causing ion suppression or ion enhancement. Unrelated metabolites having 
a similar structure may co-elute from the chromatographic column with the target 
mercapturate. The necessary removal of these interferences make sample preparation as 
critical to success as any other part of the analysis. A variety of sample preparation 
techniques have been applied in the methods reviewed. The simplest is dilution and filtration 
through 0.2 µm pore cellulose medium followed by direct injection (Yan et al., 2010). Initial 
acidification of urine is common to some sample preparation procedures, and in S-
phenylmercapturic acid analysis samples were so treated (Maestri et al., 2005, Paci et al., 
2007, Sterz et al., 2010). Other techniques use sample concentration with re-suspension in 
methanol or acetonitrile, or protein precipitation by acidification and centrifugation prior to 
analysis (Wu et al., 2012; Sterz et al., 2012; Sohn et al., 2005; Alwis et al., 2012). Most 
methods use a form of solid phase extraction (SPE) for sample preparation and clean-up. In 
SPE urine is applied to chromatographic medium, and is pulled through the medium under 
vacuum pressure. Target mercapturates are captured in the solid medium, and several 
volumes of solvent are used to remove sample matrix components. Concentrated and 
purified analytes then are washed free from the medium with elution buffer or organic 
solvent for analysis. In simple manual SPE techniques, medium in syringes, disks or 
cartridges are used to extract 1-5 ml of urine.
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Various SPE media are used to extract and concentrate target mercapturates from the urinary 
matrix: reversed phase (RP) (Li et al., 2005; Kellert et al., 2006; Kopp et al., 2008), reversed 
phase-strong anion exchange (RP-SAX) (Melikian et al., 1999), or restricted access medium 
(RAM) phase online trap cartridges (Hou et al., 2012; Schettgen et al., 2008a). Restricted 
access media are specialized chromatographic phases that combine size-exclusion with other 
retention mechanisms. Internal surface-reversed phase RAM combines silica gel particles 
having pores lined with reversed-phase C18, C8, or C4 alkane chains to retain small analyte 
molecules with an outer hydrophilic surface such as methyl cellulose.
Sample preparation is often the rate-limiting step in most bioassay methods. Automated 
sample preparation has become popular and two forms using SPE media have come into 
common use (Varma et al., 2010). Popular 96-multi-well sample plate format has been 
adapted to high-throughput SPE (Mallet et al., 2003). Strong anion exchange medium in this 
format was used to increase extraction throughput in analyses of benzene and toluene 
mercapturates for studies of benzene exposure in smokers (Li et al., 2005) and gas station 
workers (Barbieri et al., 2004) . Recently, Kuklenyik described a 96-well plate sample 
extraction and sample handling technique for analysis of four atrazine mercapturates for 
non-occupational exposure studies (Kuklenyik et al., 2012). The authors describe rapid 
optimization of sample extraction parameters, selecting between four extraction eluate 
compositions to increase analyte stability and maximize MS/MS signal intensity. Following 
extract elution into 2 µL square wells, further extract transfer and handling were eliminated 
by evaporation of extracts under nitrogen in the sample wells. Evaporated extracts were 
stored up to four days without sample degradation before reconstitution immediately before 
analysis. This format may be adapted to online analysis when high-throughput and the speed 
of fully automated analysis are necessary.
In a second form of high-throughput SPE, larger volumes of urine and high numbers of 
samples may be rapidly extracted using online sample extraction with column switching. 
Urine was passed through a trap linked to the chromatographic column using an online 
multiple valve system (Li et al., 2005; Kellert et al., 2006; Kopp et al., 2008; Hou et al., 
2012; Schettgen et al., 2008a). In this technique, target mercapturate analytes are retained in 
the trap; when valve positions are switched, urinary proteins and salts are washed away to 
waste. A final switching of valves with a change to elution buffer carries analytes from the 
trap to the HPLC column for separation. Online SPE extraction using column switching has 
grown in popularity to create automated analyses that decrease overall analysis time by a 
substantial reduction in sample preparation steps. This trend may be expected to continue in 
the future as better automated HPLC-MS/MS systems become commercially available. 
Kuklenyik has described online SPE-LC-MS/MS method design and optimization by 
presenting three example applications including a determination of two mercapturates of 
atrazine (Kuklenyik et al., 2011). Online SPE-LC-MS/MS has been used extensively by 
Schettgen and collaborators (Reska et al., 2010; Schettgen et al., 2012; Schettgen et al., 
2008a; Schettgen et al., 2009) in simultaneous determinations of biomarker mercapturates of 
aromatic compounds and volatile alkylating agents. Here rapid automated sample extraction 
and µg/L sensitivity are combined in methods for occupational and environmental exposure 
assessment to tobacco smoke and urban air pollutants in the general populations.
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Liquid Chromatography
Reversed-phase
Mercapturate metabolite analysis methods often use reversed-phase (RP) columns 
containing a non-polar stationary phase consisting of alkane chains (i.e. C18, C8 or C4). 
Commonly used mobile phases for tandem MS analysis contain volatile acids or buffers 
such as formic acid (HCOOH), acetatic acid (CH3COOH), ammonium formate 
(NH4COOH), or ammonium acetate (NH4CH3COOH). Organic modifiers such as methanol 
(MeOH) and acetonitrile (ACN) are typically used with either isocratic or gradient 
conditions for analyte elution. RP chromatography is common with ESI-MS, but has the 
major limitation in the lack of retention of highly hydrophilic, ionic or polar molecules on 
the stationary phase. Mixed mode separation has also been reported in the literature. 
Kotapati combined RP and weak anionic exchange to determine THBMA, a highly polar 
mercapturate of 1,3-butadiene (Kotapati et al., 2011).
Ultra-high performance liquid chromatography
Ongoing improvements to increase the speed and efficiency of separations are related to 
column technology and instrumentation. Ultra-high performance liquid chromatography 
(UHPLC) utilizes shorter columns, 3-5 cm long, and reduced particle sizes, smaller than 
2µm. Shorter columns result in faster analysis times, and shorter equilibration time. Reduced 
particle size decreases analyte peak dispersion, thus enhancing peak resolution. Sub-2µm 
particles produce sharper peaks while decreasing sample loading over conventional HPLC. 
These improvements in column efficiency and linear velocity can be expected to increase the 
number of theoretical plates (Varma et al., 2010). This in turn may increase sensitivity by 
increasing the signal to noise ratio of the detector. The mass spectrometer is a mass sensitive 
detector, not concentration dependent such as in ultraviolet detection; therefore, UHPLC 
may in some cases match or exceed the sensitivity of standard chromatographic systems.
The advantages of sub-2µm particles working at higher pressures were reviewed (Nguyen & 
Schug 2008). However, very high pressure is required to push mobile phase through a 
column packed with smaller diameter particles. UHPLC has come into use for biomarker 
monitoring owing to the fact that most HPLC pump manufacturers are offering pumping 
systems capable of maintaining the high back pressure levels required for the technique. 
Standard HPLC pumping systems have traditionally had maximum pressure levels of 
approximately 6,000 psi (~420 Atmospheres) while UHPLC pumps are designed to handle 
pressures in excess of 15,000 psi (~1,000 Atmospheres). These fundamental aspects and 
practical requirements of UHPLC have been reviewed (Wu & Clausen, 2007). Application 
of UHPLC specifically to bioanalysis has been reviewed (Varma et al., 2010). UHPLC 
analysis of structurally similar mercapturates found in the urine of smokers (Wu et al., 2012, 
Pluym et al., 2015) and multiple mercapturates in workers exposed to multiple volatile 
organic chemicals (Alwis et al., 2012) will be considered in later sections of this review.
Hydrophilic interaction chromatography
Biomonitoring of worker exposure to electrophilic alkylating agents that are carcinogenic, 
such as acrylamide (International Agency for Research on Cancer, 1994), acrylonitrile 
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(International Agency for Research on Cancer, 1999), styrene (International Agency for 
Research on Cancer, 1994) and 1,3-butadiene (International Agency for Research on Cancer, 
2008), is important in industrial medicine (De Rooij et al., 1998; Vanwelie et al., 1992). The 
mercapturates of these compounds are polar, especially those containing hydroxylalkyl 
groups. These hydroxyalkyl mercapturates (HAMAs) are difficult to retain on RP columns 
without using highly aqueous conditions and non-volatile mobile phase components that are 
not compatible with mass spectrometric detection. Ordinarily normal phase (NP) would be 
used to satisfy the separation conditions of highly polar analytes (Snyder et al., 2010), but 
NP is not easily made compatible with electrospray ionization MS (ESI-MS). Hydrophilic 
interaction chromatography (HILIC) has been used to overcome the mismatch between NP 
like chromatography and ESI-MS. Typically HILIC mobile phases using high organic 
content (> 80%) are ideal for ESI-MS analysis, and may enhance ES-MS response (Nguyen 
& Schug, 2008). HILIC utilizes a polar stationary phase with an aqueous/polar organic 
solvent mobile phase, where water is introduced to play the role of a stronger eluting 
solvent. In HILIC separations, mercapturates are separated from urinary matrix by a 
partitioning mechanism between a water-enriched layer associated with a polar stationary 
phase and solvent containing ammonium formate or ammonium acetate and 5-15% water to 
maintain the water-enriched layer on the stationary phase. Since retention increases with 
hydrophilicity and polarity of the analyte, elution is driven by increasing water content in the 
mobile phase which is composed of high organic content, usually consisting of acetonitrile 
or alternatively, methanol. The HILIC mechanism has been discussed in great detail 
(Hemstrom & Irgum, 2006) and the advantages of HILIC when combined with ESI-MS 
detection have been reviewed (Nguyen & Schug, 2008). The application of HILIC in 
quantitative bioanalysis of compounds of pharmaceutical interest has been described (Jian et 
al., 2010).
HILIC columns have been reported for the determination of mercapturates having greater 
molecular polarity (Kopp et al., 2008; Yan et al., 2010; Sterz et al., 2012; Eckert et al., 
2010), and this technique has become an important recent trend in mercapturate analysis. 
HILIC-ESI-MS appears to be a useful technique, and has been used as a complement to 
RPLC-ESI-MS studies by Dekant and collaborators (Kellert et al., 2006; Kopp et al., 2008) 
in complementary studies of acrylamide and glycidamide mercapturates and other polar 
acrylamide metabolites (Table 2). Kopp used HILIC-ESI-MS to achieve baseline separation 
between two acrylamide metabolites, AAMA-sulfoxide and GAMA. Failure to resolve these 
two metabolites could result in over estimation of urinary GAMA levels, and hence an over 
estimation of the potential risk of AA exposure in humans. A direct-injection method (Yan et 
al., 2010) was developed using HILIC to eliminate sample extraction used in earlier methods 
(Mascher et al., 2001; Carmella et al., 2007) to quantitate the acrolein mercapturate 3-
HPMA. The method specificity, linearity, precision and accuracy met required FDA criteria 
(US Department of Health and Human Services, Food and Drug Administration, 2001). 
HILIC chromatography has also been used to simultaneously determine HAMAs of multiple 
alkylating agents in a single chromatographic run (Sterz et al., 2012; Eckert et al., 2010). 
These studies are considered later in this review describing simultaneous determination of 
mercapturates in a single chromatographic analysis.
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Mass spectrometry modes of detection
In tandem HPLC/MS analysis, after target analytes are separated by chromatography, they 
are introduced into the mass spectrometer for analysis. This is done at the LC/MS interface 
where the chromatographic eluate is vaporized and the analyte molecules are ionized for 
mass selection and detection in the mass analyzer. The ion sources used in the methods 
reviewed here are electrospray ionization (ESI) and atmospheric chemical ionization 
(APCI). These ionization techniques allow easy and robust interfacing of HPLC to tandem 
mass spectrometry (Zimmer, 2003).
In ESI, the liquid eluent from the HPLC system is passed through a small capillary needle 
held at a high electrical potential (2000 – 5000 V). This results in electrostatic nebulization 
of the liquid into droplets. The resultant droplets contain a net charge having the same 
polarity as the voltage placed on the needle. During desolvation of the droplets, the electric 
field increases in strength at the diminishing droplet surface and leads to the ejection of 
charged analyte ions upon final evaporation. The ESI source is a gentle and “soft” ionization 
technique and does not cause significant thermal degradation as that caused by other ion 
sources. ESI is able to ionize extremely polar/non-volatile molecules, which may be more 
difficult for APCI; thus, it is generally considered more versatile than APCI. ESI also has a 
high level and efficiency of ionization, which leads to a higher level of detector sensitivity. 
ESI sources generally require water and acidic pH of the mobile phase to aid in ionization.
In APCI , the liquid eluent from the HPLC is heated and aerosolized by means of a nebulizer 
and a high flow of nitrogen gas. The aerosol is subjected to a corona discharge to form ions 
in a three step process. First, a corona discharge ionizes the nebulizing gas to form primary 
ions. These primary ions react immediately with the solvent molecules of the mobile phase 
forming reagent ions. Finally, the reagent ions react with the analyte molecules to form [M + 
H]+ in positive-ion mode or [M – H]− in negative-ion mode. In APCI, this cascade of 
ionization reactions occur in the gas phase, unlike ion formation from the liquid phase as in 
ESI. The APCI source allows for improved analysis of non-polar and medium polar volatile 
compounds. APCI is generally regarded as a more robust ionization method than ESI, and it 
is less susceptible to signal suppression resulting from co-eluting matrix components 
(Ackermann, et al., 2002, Korfmacher 2005, Matuszewski et al., 1998). APCI also requires 
little or no buffers in aqueous mobile phases to assist in ionization.
The basic function of a mass spectrometer is to measure the mass-to-charge ratios (m/z) of 
analyte ions. Mass spectrometers have various designs which have been reviewed elsewhere 
in the literature (Goddlett et al., 2001). Although mass spectrometers are used in qualitative 
identification of compounds, the monitoring of specific ions for quantitative determination is 
the focus of this discussion. For the mercapturate analyses surveyed for this review, single 
quadrupole (SQ) mass analyzers and tandem mass spectrometers using the triple quadrupole 
(QQQ) design dominate what is reported in the literature (Tables 2-3). The mass analyzer of 
the spectrometer separates the formed precursor ions. Analysis of analytes using single 
quadrupole instruments are performed in Selected Ion Monitoring (SIM) mode in which 
only a selected m/z value is detected in the analysis. The majority of the methods found in 
this review use tandem transmission quadrupole instruments (MS/MS). In the case of 
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multiple mercapturic acid metabolite analysis, all use the QQQ where precursor ions are 
selected in the first quadrupole, and allowed to pass into a collision chamber for collision-
induced dissociation fragmentation into product ions. Transmitted from the collision 
chamber, fragmentation product ions will be separated by the third quadrupole for detection. 
Tandem mass spectrometry provides the greatest level of sensitivity and specificity for the 
analysis method. This allows for detection of analytes in the presence of biological sample 
matrix components that would otherwise interfere with ultraviolet or fluorescence detection 
(B'Hymer & Cheever, 2010). For this reason, tandem MS detection is considered the method 
of choice for quantitation of metabolites in biological fluids (Matuszewski et al., 2003). The 
high sensitivity of the MS/MS detection is of particular importance in investigating low-level 
pollutant exposure in general populations in whom urinary mercapturates may be present in 
µg/L or ng/L levels.
Signal suppression is a well known problem in HPLC-MS/MS analysis. The most common 
problem is that of ion suppression; the problem of ion enhancement, although rare, may also 
be encountered (Matuszewski et al., 1998). Both manifestations can be caused by sample 
matrix interferences from components within the sample. The mechanism of matrix induced 
ion suppression or enhancement is not fully understood (Kebarle & Tang, 1993, King el al., 
2000). It is thought to originate from the competition between the target analyte and a co-
eluting, undetected sample component reacting with the primary ions formed in the HPLC-
MS/MS. This type of matrix effect may greatly change the reproducibility or the quantitation 
accuracy of a particular analyte.
Compensation for signal suppression by the use of an internal standard is a common strategy 
used in HPLC-MS/MS. The use of an internal standard will only be effective if the internal 
standard is subject to the same type of matrix effect as the analyte and must essentially 
chromatographically co-elute with the target analyte. Thus, ideally, the best internal standard 
is the stable isotopically labeled target analyte or a chemically similar homolog of the target 
analyte. For example, deuterated or carbon-13 analogues of the target analytes are typically 
used as internal standards. The internal standard is added to both the initial sample and 
spiked sample solutions before analysis. Calibration plots using analyte/internal standard 
peak-area ratios generated from the chromatograms, rather than the peak area of the target 
analyte alone, are then used to calculate accurate results. At the time of this writing, both 
analytical and isotopically labeled standards for the mercapturates reviewed in this work 
(Table 1) are commercially available or available through custom synthesis. Seven 
commercial sources of mercapturic acids are listed by Alwis et al., and many others are 
available (Alwis et al., 2012). This was not the case in several earlier published methods 
reviewed here when researchers used general methods of laboratory synthesis to produce the 
required mercapturate standards (Van Bladeren et al., 1980).
Mercapturates as indicators of toxicant metabolism
The metabolism of occupational and environmental toxicants in exposed individuals varies 
with toxicant dose, absorption and enzyme polymorphisms (De Rooji et al., 1998; Vanwelie 
et al., 1992). The excretion of mercapturates subsequently varies and their quantitation offers 
information about individual occupational and environmental exposure, internal dose and 
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differences in metabolism. Metabolic activation of an electrophilic compound can produce 
multiple metabolites many of which may react with GSH to form a mercapturate. The 
determination of one or more mercapturate products of a parent compound may be required 
for informative biomonitoring (De Rooji et al., 1998; Vanwelie et al., 1992). The metabolism 
of several environmental toxicants and the formation of their mercapturates will be described 
briefly: these include acrylamide, acrylonitrile, 1,3 butadiene, benzene, toluene, styrene, 1-
bromopropane and polycyclic aromatic hydrocarbons. These examples demonstrate broadly 
how mercapturate determination is used in exposure biomonitoring and in the investigation 
of toxicant metabolism. Toxicant metabolism may include biological activation, 
detoxification and elimination of mutagenic or carcinogenic toxicants.
Acrylamide
Acrylamide (AA) is an extensively used industrial chemical intermediate with many 
applications such as a polymerizing agent in grouts or other acrylamide polymers used in 
waste water treatment, soil stabilization and paper manufacture (Friedman, 2003). Low 
levels of acrylamide are present in baked, fired, and roasted foods, and mainstream and 
sidestream tobacco smoke are common sources of human exposure (Tornqvist, 2005). Both 
AA and its oxidative metabolite glycidamide (GA) contain electrophilic groups capable of 
binding to cellular proteins, a property associated with acrylamide neurotoxicity. 
Furthermore, GA, a reactive epoxide, binds to nucleophilic nucleic acids to form adducts 
with cellular DNA; this mechanism is regarded as the cause of AA carcinogenicity 
(International Agency for Research on Cancer, 1994). Thus, in human biomonitoring and 
health risk assessments of AA elimination routes, the metabolism and conversion to GA 
must be considered. AA may be detoxified by direct conjugation with GSH to form AAMA, 
Figure 2. GSH conjugation of GA, an epoxide, leads to formation of two isomeric 
mercapturates GAMA2 and GAMA3. Quantification of AAMA is a measure of direct 
detoxification of AA, while determination of GAMA2 and GAMA3 measures AA 
bioactivation to a direct-acting mutagen. HPLC/MS analysis has been adapted to these 
purposes, and five examples of this are listed in Table 2 (B’Hymer & Cheever, 2007; Li et 
al., 2005; Kellert et al., 2006; Kopp et al. 2008; Zhang et al., 2015). A method for 
simultaneous determination of urinary AA and the mercapturate, AAMA, was developed for 
occupational exposure monitoring (B'Hymer & Cheever, 2007). As indicated previously, AA 
exposure is not limited to the industrial environment. To examine the health risk posed by 
AA in food, methods for simultaneous quantitation of AAMA and of GA isoform 
mercapturates, GAMA2 and GAMA3, have been developed and reported in the literature 
during epidemiologic studies for dietary AA conversion to GA in non-occupationally 
exposed populations (Kellert et al., 2006; Kopp et al., 2008; Zhang et al., 2015).
Acrylonitrile
Acrylonitrile (AN) a widely-used industrial chemical and component in tobacco smoke, is a 
thoroughly characterized chemical exposure hazard (International Agency for Research on 
Cancer, 1999). Acrylonitrile is not directly carcinogenic, but like acrylamide, is potentially 
carcinogenic through an oxidative metabolite, cyanoethylene-epoxide (CEO) (Hou et al., 
2012; Wu et al., 2012; Schettgen et al., 2012). If this epoxide is not detoxified by GSH 
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conjugation or other mechanism, it can react with nucleophilic sites in DNA and function as 
direct-acting mutagens. AN is detoxified by direct GSH conjugation to form 2-cyanoethyl 
mercapturate (CEMA). CEO is detoxified and eliminated as 2-hydroxyethyl mercapturate 
(HEMA) or 1-cyano-2-hydroxyethylmercapturate (CHEMA), Figure 3. Taken together 
CEMA, HEMA and CHEMA quantitation represent conjugative detoxification of AN, while 
HEMA and CHEMA quantitation is a measure of metabolic activation of AN to the reactive 
epoxide, CEO.
Aromatic Solvents
Benzene and toluene are aromatic hydrocarbons used as solvents in industrial chemicals, as 
common additives in fuels and are components in cigarette smoke. Benzene is a human 
cancer hazard (International Agency for Research on Cancer, 1982), and the hematotoxicity 
of benzene has been elucidated during the past few decades (Arnold et al., 2013). A non-
carcinogen toluene (International Agency for Research on Cancer, 1989) is often used as a 
less toxic substitute for benzene in inks, dyes, thinners, detergents and in chemical and drug 
preparation (American Conference of Governmental Industrial Hygienists, 2014) . 
Historically, biological monitoring for both chemicals was done using their hydrolytic 
detoxification products. In the case of benzene, four metabolites, phenol, catechol, 
hydroquinone and trans, trans-muconic acid (ttMA), have been investigated and used as 
biomarkers (American Conference of Governmental Industrial Hygienists, 2014). However, 
their urinary levels are influenced by the metabolism of gut flora, diet, and medication use, 
and smoking (Arnold et al., 2013). Similarly, the metabolism of toluene produces two 
hydrolytic metabolites, hippuric acid and o-cresol, that are influenced by diet and are not 
specific for occupational exposure (Cosnier et al., 2013). However, GSH detoxification of 
both these solvents produces corresponding mercapturates which may be used as biomarkers 
of exposure. Benzene metabolism forms phenylmercapturic acid (PMA) and toluene forms 
benzylmercapturic acid (BMA). Because a biomarker of exposure should be specific for 
chemical exposure, PMA and BMA that are free of dietary and endogenous interferences are 
preferred biomarkers for benzene and toluene exposure (Arnold et al., 2013; Cosnier et al., 
2013). However, both are influenced by smoking. Therefore, in biomonitoring, study 
subjects are asked to refrain from smoking for 2 h before urine collection (Lovreglio et al., 
2010).
In addition to toluene’s side chain glutathione metabolite BMA, 3 isomeric 
toluylmercapturates resulting from the arene oxidation of toluene’s aromatic ring may be 
found in rat urine (Cosnier et al., 2012). One of these, S-p-toluylmercapturate, was 
demonstrated in urine from toluene exposed workers, and has been proposed as a biomarkers 
of exposure (Angerer et al., 1998). Similarly, arene oxidation of the aromatic ring in xylene 
and ethylbenzene lead to the formation of isomeric mercapturates (Gonzalez-Reche et al., 
2003; Cossec et al., 2013).
1-Bromopropane
1-Bromopropane (1-BP) is an industrial solvent used as a substitute for chlorofluorocarbons 
or 1,1,1-trichloroethane in metal electronics degreasing, in adhesives, in aerosol solvents, or 
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in place of trichloroethylene or perchloroethylene in dry cleaning (National Institute for 
Occupational Safety & Health, 2013). Worker case studies report that 1-BP exposure causes 
central and peripheral neurological disorders and changes in cellular blood components in 
workers including evidence of dose-dependent neurological and hematological changes in 
women working in 1-BP production plants (Sclar, 1999; Ichihara, 2005; Raymond & Ford 
2007; Majersik et al., 2007; Morbidity Mortality Weekly Report, 2008; Li et al., 2010). 
Available epidemiologic studies have not reported cancer in humans exposed to 1-BP. 
However, based on recent animal studies, the National Toxicology Program concluded 1-BP 
is reasonably anticipated to be a human carcinogen. In these studies, the molecular 
alterations observed in experimental rodents that are associated with oxidative metabolism, 
genotoxicity and carcinogenesis are relevant to possible mechanisms of carcinogenicity in 
humans (US Department of Health and Human Services Public Health Service National 
Toxicology Program, 2014). At the time of this writing, there are no standardized biological 
monitoring techniques for 1-BP. To compare and evaluate the suitability of several 1-BP 
metabolites as biomarkers of occupational exposure, recent animal exposure and human 
exposure studies are considered.
The metabolism of 1-BP is complex (Barnsley et al., 1966; Sklan & Barnsley, 1968; Baines 
et al., 1977; Jones & Welsh, 1979; Tachizawa et al., 1982). In rats, some absorbed 1-BP is 
metabolized rapidly through direct conjugation with GSH to form n-propylmercapturate 
with the release of free bromide (Br−) ions (Jones & Welsh, 1979). Mercapturate formation, 
investigated most completely in rodents, produces four mercapturates; n-
propylmercapturate, and three more derived from C2 or C3 oxidations of 1-BP by 
cytochrome P450 2E1 monooxygenase (CYP2E1). Oxidative metabolites 1-bromo-2-
propanol and bromoacetone (Barnsley et al., 1966) and 3-bromopropionic acid (Jones and 
Walsh, 1979) are, in turn, conjugated with GSH to form 2-hydroxypropyl-mercapturate, 2-
oxopropylmercapturate, and 2-carboxyethylmercapturate, respectively (Figure 4).
Human exposure studies investigated urinary bromide level (Br−) as a possible biomarker of 
1-BP exposure using gas chromatography with electron capture detection (Kawai et al., 
2001; Kawai et al., 2002; Zhang et al., 2001). The correlation between urinary Br− and 
airborne 1-BP was significant, but background urinary Br− was substantial (~8 mg/l). 
Further investigation found that intake of fruit, sea-food, some soft drinks, and use of 
brominated vegetable oils influenced urinary Br− levels (Kawai et al., 2002; Zhang et al., 
2001, Horowitz 1997). This lack of specificity limits the use of urinary Br− levels for 
estimating human occupational exposure only when dietary or other bromide intake can be 
considered. Alternatively, other metabolites identified in rodents are specific products of 1-
BP oxidation by CYP2E1; 1-bromo-2-propanol, bromoacetone and 3-bromopropionic acid. 
Their mercapturates represent specific biomarkers that are free of dietary or other non-
occupational interferences (Pombrio et al., 2001; Ichihara et al., 2001; Valentine et al., 
2007). Urinary n-propylmercapturate levels were measured using GC/MS in post-shift urine 
samples of 47 workers in a 1-BP production plant. Urinary n-propylmercapturate levels 
increased with increasing 1-BP exposure in these workers (Valentine et al., 2007). 
Investigation of this mercapturate and one oxidative metabolite precursor, 3-bromopropionic 
acid (3-BPA), as potential biomarkers of 1-BP exposure in highly exposed workers was 
performed in this laboratory (Mathias et al., 2012). HPLC/MS was used to quantify urinary 
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mercapturates of 1-BP (Cheever et al., 2009) where the direct GSH conjugate, n-
propylmercapturate was predominate in urine specimens taken from the most heavily 
exposed workers. The same urine samples when analyzed for 3-BPA using GC/MS 
(B'Hymer & Cheever, 2004) contained no 3-BPA. This result suggests that the predominate 
n-propylmercapturate, the product of direct conjugate of 1-BP with GSH, is a major 
detoxification route in highly exposed workers, and that oxidative metabolism of 1-BP is not 
a major metabolic pathway in humans. Studies of human metabolism of 1-BP are limited to 
analysis of n-propylmercapturate in worker urine (Ichihara et al., 2001; Valentine et al., 
2007), and provide no explanation for these results. However studies of oxidative 
metabolism of 1-BP by CYP2E1 in rodents by Garner demonstrated that 1-BP metabolism 
becomes saturated in highly exposed rats, but not in mice (Garner et al., 2006). In rats, 1-BP 
oxidative metabolism by CYP2E1 is dose-dependent and becomes blocked with increased 
toxicant dose. As a result n-propylmercapturate becomes a predominate urinary 
mercapturate. When 1-aminobenzotriazole, an inhibitor of oxidative metabolism was given 
to rats, all oxidative metabolites including 3-BPA, were eliminated from their urine leaving 
only n-propylmercapturate as the predominate urinary mercapturate, mirroring the effect of 
metabolite saturation of CYP2E1 activity that likely occurs in high 1-BP exposure in 
humans. These results suggest a difference between human and rat metabolism of 1-BP and 
that found in mice. In these studies urinary mercapturate identification was used to 
investigate species differences in toxicant metabolism, and to deduce possible changes in the 
activity of up-stream metabolic pathways when the conditions of toxicant exposure in 
research animals or workers are changed. In summary, the mercapturates of 1-BP are 
specific for 1-BP exposure while bromide ion levels are not. Oxidative metabolites of 1-BP, 
3-BPA or others are specific, but may not be produced during high exposures. Given these 
considerations, n-propylmercapturate, the product of direct GSH conjugation of 1-BP 
appears to be the best candidate biomarker of 1-BP exposure.
1,3-butadiene
The genotoxicity of butadiene (BD) is attributed to its three epoxide metabolites 
epoxybutene (EB), diepoxybutane (DEB) and epoxybutanediol (EBD), each of which is able 
to react with cellular protein such as hemoglobin, or with DNA as direct acting carcinogens 
(International Agency for Research on Cancer, 2008). Assay of their detoxification 
mercapturate products are useful to measure BD exposure, epoxide formation and 
detoxification, and may then be used to estimate genotoxic risk of exposure (Figure 5). 
Occupational exposure studies of BD monomer and rubber workers have used the EB 
mercapturate metabolite, 3,4-dihydroxybutylmercapturate (DHBMA) alone (Kelsey et al., 
1995; Ward et al., 1996; Hallberg et al., 1997; Ammenheuser et al., 2001) or both EB 
mercapturates, DHBMA and 1-hydroxymethyl-2-propenylmercapturate (MHBMA) in 
rubber workers (Hayes et al., 2000; Fustinoni et al., 2004; Albertini et al., 2003), smokers 
(Urban et al., 2003), urban traffic workers (Sapkota et al., 2006), and in an unexposed 
population (Schettgen et al., 2009). The ratio of these mercapturates DHBMA/(DHBMA + 
MHBMA) serves as a relative comparison of hydrolytic detoxification vs. direct GSH 
conjugative detoxification of EB (Urban et al., 2003; Kirman et al., 2010b). This ratio was 
used to examine species differences in BD metabolism (van Sittert et al., 2000) An 
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understanding of these differences is necessary for accurate human risk analysis when 
toxicokinetic data based on more easily studied rodent metabolism is used when data from 
human volunteer or occupational exposure studies are limited (Richardson et al., 1999; van 
Sittert et al., 2000, Kirman et al., 2010a).
Alternative metabolism of EB leads to further epoxide formation to produce EDB and DEB. 
Of these EDB is the most abundant BD epoxide metabolite in humans (Swenberg et al., 
2007). Formation of both epoxides has been investigated in exposed workers by 
measurement of their hemoglobin adduct, N-(2,3,4-trihydroxybutyl)-valine (THB-Val) 
(Perez et al., 1997; Hayes et al., 2000; Albertini et al., 2001, 2003; Fustinoni et al., 2002; 
Vacek et al., 2010). This measurement requires a blood specimen, and the analysis is 
technically demanding and expensive. Alternatively, determination of urinary 2,3,4-
trihydroxybutylmercapturate (THBMA), the detoxification mercapturate of both EDB and 
DEB is an indirect measure of BD metabolism to EDB and DEB. THBMA is the most polar 
of the detoxification mercapturates of BD, and is poorly retained on reverse phase media 
typically used in solid phase sample extraction and chromatography of less polar 
mercapturates. Kotapati adapted the method of Eckert using acidic sample extraction 
conditions to neutralize the carboxylate group of THBMA, improving analyte binding to the 
solid phase (Kotapati et al., 2011; Ekert et al., 2010). Chromatography was performed using 
mixed mode reversed phase with weak anionic interaction to separate THBMA from other 
sample components. This method was expanded to include analysis of bis-BDMA, a 
mercapturate of DEB, as well as DHBMA and MHBMA for quantitation of all four 
mercapturates of BD (Kotapati et al., 2014). These recently developed HPLC/MS-MS 
methods for quantitation of urinary THBMA and bis-BDMA represent more cost effective 
biomarkers of EDB and DEB epoxide formation from BD than the currently used analysis of 
THB-Val adducts of hemoglobin.
Styrene
Styrene is an industrial monomer used worldwide in polymers, resins, latex paints and in 
manufactured building materials. The highest exposure potential occurs in open 
manufacturing of reinforced plastics and in hand-lamination workers (Miller et al., 1994). 
Oxidative metabolism of styrene occurs via two pathways both leading to products that 
contribute to its toxicity. Bioactivation may occur through oxidation of styrene’s side chain 
to form styrene-7,8 epoxide (7,8-SO) a recognized animal carcinogen and a possible human 
carcinogen (International Agency for Research on Cancer, 1994). In humans the most 
abundant urinary metabolites, mandelic acid (MDA) and phenylglyoxylic acid (PGA), which 
represent the hydrolytic detoxification of SO, are used currently in occupational 
biomonitoring (American Conference of Governmental Industrial Hygienists, 2014). These 
metabolites are not specific for occupational exposure since trace amounts of styrene occur 
naturally in fruits, vegetables, nuts, beverages and in meats. In addition, styrene exposure 
may occur through tobacco smoke, consumer products and styrene vapor from building 
materials (American Conference of Governmental Industrial Hygienists, 2014). Because 
MDA and PGA are non-specific, occupational exposure must be confirmed by measuring 
styrene in whole blood drawn at the end of the workday (American Conference of 
Governmental Industrial Hygienists, 2014). Alternative detoxification of 7,8-STO by GSH 
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conjugation leads to formation of four isomeric phenylhydroxyethyl mercapturates 
(PHEMAs).
Investigations of styrene mercapturate formation have provided important information about 
the stereochemistry of styrene biotransformation (Figure 6). Oxidation of the side chain of 
styrene forms two stereoisomers of styrene epoxide, (S)7,8-STO and (R)7,8-STO. Each 
epoxide enantiomer when conjugated with GSH at either C7 or C8 of the side chain leads to 
two isomeric mercapturates designated PHEMA MA1 and MA2. GSH conjugation of both 
S- and R- enantiomers yields four possible isomeric PHEMAs, the structures of which are 
shown in Figure 6 (Linhart et al., 1998). The relative proportions of the stereoisomers MA1 
and MA2 was used to investigate the stereoselectivity of GSTM1 conjugation of 7,8-SO 
(Linhart et al., 1998, DePalma et al., 2001, Fustinoni et al., 2008). The most abundant 
stereoisomers R,R-MA1 and S,R-MA2 are derived from the less genotoxic (S)7,8-SO. This 
result suggests stereoselective conjugation of (S)7,8-SO at a less sterically hindered C8 over 
a more hindered C7 (Fustinoni et al., 2008). Formation of these mercapturates is a minor 
detoxification route, representing about 1% of inhaled styrene (Manini et al., 2003), but 
tandem HPLC/MS-MS analysis of these mercapturates offers a sensitive and specific tool for 
styrene biotransformation studies (Manini et al., 2000).
A second minor pathway of styrene bioactivation proceeds via oxidation on the aromatic 
ring to form arene oxides 2,3 and 3,4-styrene oxide (2,3 and 3,4-STO, respectively, Figure 
7). 3,4-STO in turn may form 4-vinylphenol (4-VP), which has been found in the urine of 
workers exposed to styrene (Pfaffli et al., 1981; Haufroid et al., 2002; Manini et al., 2003; 
Watabe et al., 1982). 4-VP is more hepatotoxic and pneumotoxic than styrene and 7,8-STO 
at lower doses in rats and mice (Carlson, 2002; Carlson, 2004). Further studies indicate 4-
VP metabolites including 4-vinyl catechol, -4-(2-oxiranyl)-phenol, and electrophilic 
quinones could contribute to the hepatotoxicity of 4-VP (Carlson, 2004; Carlson, 2011; 
Zhang et al., 2011). Alternatively 2,3- and 3,4-STO may react with GSH to initiate 
formation of three isomeric vinylphenolmercapturates (VPMAs). Of these mercapturates, 4-
VPMA, the product of 3,4-STO conjugation, is the most abundant VPMA isomer (Linhart et 
al., 2010; Linhart et al., 2012). The mercapturate products of 2,3-STO conjugation, 2- and 3-
VPMA were detected only in trace amounts suggesting selective GSH conjugation at C4 of 
3,4-STO over conjugation of 2,3-STO (Linhart et al., 2012). Formation of these 
mercapturates represents activity in a second toxicologically significant pathway of styrene 
activation and biotransformation (Linhart et al., 2012), Table 2). Although determination of 
these styrene mercapturates provides toxicologically relevant information, they are minor 
metabolites and do not reflect absorbed dose as accurately as the currently used biomarkers 
MDA and PGA (De Palma et al., 2001).
The biotransformation of styrene is complex, but the sensitivity and specificity of tandem 
HPLC/MS analysis will make possible complete characterization of styrene metabolites in 
occupational settings (Manini et al., 2000; Manini et al., 2002) and in the low level 
exposures found in the general environment (Reska et al., 2010). Because the mercapturates 
of styrene are minor metabolites, they are not suited for quantitative estimates of internal 
absorbed dose. They are indicators of oxidative activation of styrene and are products of 
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toxicologically relevant pathways of transformation. Their possible use as biomarkers of 
styrene activation and biotransformation awaits further study.
Simultaneous determinations mercapturates in occupational and 
environmental studies
In the past, one of the main technological limitations of mass spectrometers used in HPLC 
analysis has been the rate of data acquisition and the dwell time of monitoring the response 
at specific masses. Detector sampling rates must be rapid enough to obtain a sufficient 
number of data points across the analyte peak (Holland et al., 1983; Varma et al., 2010). 
Low data acquisition rates have been known for many years to lead to poor chromatographic 
peak integration and poor reproducibility of peak area determinations (Holland et al., 1983). 
Rapid data acquisition is necessary in order to minimize chromatographic peak distortion, 
which can be a problem with multiple analyte methods or spectral data collected from 
increasingly narrow chromatographic peaks such as with UHPLC. With improvements in 
data aquisition rate for MS systems, mostly from the advent of much more powerful 
computers, HPLC-MS methods have become more capable of determining multiple 
mercapturate analytes in a single chromatographic analysis. The following sections consider 
simultaneous determinations of the mercapturates of multiple parent compounds in a single 
chromatographic analysis.
Polycyclic aromatic hydrocarbons
The carcinogenicity of benzo(a)pyrene (BP) is associated with diol epoxide formation by 
P450 oxidation in the bay region of this polycyclic aromatic hydrocarbon (PAH). 
Inactivation and detoxification of BP was generally assumed to occur by Glutathione S-
Transferase (GST) catalyzed GSH conjugation of bay region diol epoxides followed by 
further metabolism to urinary mercapturates, Figure 8. Molecular epidemiology and risk 
assessment studies based on this assumption had met only modest success (Upadhyaya et al., 
2006). In investigating possible reasons for this, Hecht and collaborators recognized that the 
expected mercapturate products of GSH conjugation in the bay region of PAHs had never 
been demonstrated in human urine. To reexamine the detoxification of PAHs, Upadhyaya 
developed a method to determine the mercapturates of phenantherene, the simplest of the 
PAHs having a bay region. The method was applied to the urine of 36 smokers. Detectable 
mercapturate were products of conjugation of the “reverse diol epoxides” of phenantherene, 
Phe-O-Nac and Phe-DE-Nac, and not products of GSH conjugation at the bay region 
(Upadhyaya et al., 2006; Hecht et al., 2008). The result was replicated in human hepatocyte 
culture where only trace amounts of mercapturates derived from the bay region of 
phenantherene were detected (Hecht et al., 2009). These results suggested that GST may 
have a substrate preference for GSH conjugation of reverse diol epoxides over those formed 
in the bay region of PAHs (Figure 8). Upadhyaya repeated hepatocyte incubations with 
culture medium containing the activated metabolite of BaP, 7,8-diol-9,10-epoxide (BPDE), 
or with the non-carcinogenic reverse diol epoxide 9,10-diol-7,8-epoxide (revBPDE). The 
majority of mercapturate products, again, were formed by preferential GSH conjugation of 
revBPDE by GST (revBPDE-7Nac). Mercapturate products of conjugation in the bay region 
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of BPDE were detected in only one of ten replicate incubations (Upadhyaya et al., 2010). 
These studies indicate that detoxification of BPDE by GSH conjugation is a minor pathway 
in humans, and that the gene polymorphisms of GST are not an important risk factor in the 
diol epoxide pathway of benzo(a)pyrene carcinogenesis.
Alkylating agents
Schettgen has developed RP simultaneous determinations for the mercapturates of high 
volume production alkylating chemicals acrylamide, acrolein, dimethylformamide, ethylene 
and propylene oxides (Schettgen et al., 2008b) and for acrylonitrile and 1,3-butadiene 
(Schettgen et al., 2009). These methods were applied to spot urine samples collected from 
smokers and non-smokers having no occupational exposure. Both methods were sensitive 
enough to distinguish between smokers and non-smokers and would be suitable for 
determination of background exposures of general populations to industrial emissions and 
polluted urban air.
The mercapturates of many alkylating agents contain highly polar hydroxyalkyl groups and 
are difficult to retain on RP media. To address this difficulty, Eckert et al. (2010) developed a 
HILIC method to determine six hydroxyalkyl mercapturates (HAMA), including the first 
reported determination of 2,3-dihydroxypropyl mercapturate of glycidol (Table 3). In 
agreement with earlier reports (Schettgen et al., 2009; Ding et al., 2009), Eckert reports only 
1 MHBMA peak in urine of smokers. Most recently, Sterz combined UHPLC with HILIC to 
separate 1,3-butadienemercapturate isomers, MHBMA1 and MHBMA2 in human urine 
(Sterz et al., 2012, Table 3). Altogether, further studies are needed to better evaluate 1,3-
butadiene metabolism. Perhaps, as in the complementary studies of acrylamide by Dekant 
and collaborators (Kellert et al., 2006; Kopp et al., 2008), RPLC-ESI-MS/MS and HILIC-
ESI-MS/MS may be used to investigate the isomers of MHBMA, and evaluate their utility as 
biomarkers in occupational exposure, in smokers, and in urban populations.
Urban air pollutants
Simultaneous determination analysis is well suited to investigate complex exposures to 
volatile organic compounds (VOC) in occupational settings, in exposure of urban 
populations to air pollutants, and in cigarette smoke (Schettgen et al., 2008b; Ding et al., 
2009; Scherer et al., 2010; Eckert & Goen, 2014; Zhang et al., 2014; Chiang et al., 2015; Li 
et al., 2015b; Pluym et al., 2015). Sabatini developed a simultaneous determination for the 
mercapturates of benzene, toluene and xylene (BTX) using FDA validation guidelines (US 
Department of Health and Human Services Food and Drug Administration, May 2001) to 
measure BTX co-exposure in traffic warden exposures to automobile exhaust and urban air 
pollutants examining the urine of men and women, including smokers and non-smokers 
(Sabatini et al., 2008, Table 3). To study urban populations exposed to cigarette smoke, Wu 
used an ultra-high performance small bore column to resolve structurally similar 
mercapturates of acrylonitrile, CEMA and HEMA (Wu et al., 2012). UHPLC was used 
ambitiously by Alwis et al. to determine 24 mercapturate metabolites of 15 VOCs in the 
urine of multi-ethnic males and females including both smokers and non-smokers (Alwis et 
al., 2012). Target mercapturates of this study included a 3rd isomer of 1,3-
Mathias and B’Hymer Page 16
Biomarkers. Author manuscript; available in PMC 2017 June 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
butadienemercapturate, 4-hydroxy-2-buteneylmercapturate (MHBMA3). Although multiple 
analyte analysis is an obvious modern trend, the rate of data acquisition must be kept in 
mind when developing and validating new biomarker analytical methods (Holland et al, 
1983). Low data acquisition rates can lead to distorted peak shape, poor peak area 
integration, and ultimately inaccurate quantitation.
Scherer used pentafluorobenzyl-bromide (PFBBr) derivitization to determine exposure to 
alkylating agents in tobacco smoke for use in cigarette testing and smoking cessation studies 
(Scherer et al., 2010). Mercapturate analytes were enriched in urinary extracts by reaction 
with PFBBr and extracted twice with ethyl acetate for analysis. The method was developed 
using FDA guidelines for bioanalytical methods (US Department of Health and Human 
Services Food and Drug Administration, May 2001). Method calibrations were performed in 
human urine to simulate ion suppression interferences from a urinary sample matrix. The 
validated method achieved the required specificity and sensitivity to distinguish between 
mercapturate levels in smokers of conventional cigarettes, test cigarettes with activated 
carbon filters, or an electronically heated smoking system. After smoking cessation, the 
method detected 74% and 90% reductions in the mercapturates of ethylene oxide and 
acrylonitrile, respectively. Details of the study designs, study participant characteristics and 
cigarette characteristics are reported elsewhere (Frost-Pineda et al., 2008; Sarkar et al., 
2008).
Herbicides
Triazine and chloroacetamide herbicides are extensively used in commercial, agricultural, 
urban and residential settings and have become ubiquitous environmental pollutants. 
Sensitive, automated high throughput methods for occupational and environmental 
biomonitoring of atrazine (ATZ) exposure were developed by Barr and collaborators 
(Panuwet et al., 2008; Norrgran et al., 2006; Kuklenyek et al., 2012). By combining RP-
hexyl phenyl chromatography with APCI ionization and multiple precursor-product ion 
monitoring (RP-APCI-MRM), these methods allow simultaneous determination of urinary 
ATZ, ATZ metabolites, their mercapturates and hydroxylated derivatives. The analysis was 
adapted to water and urine samples by adding online SPE extraction and concentration of 
analytes to determine ATZ, two ATZ mercapturates, and four other ATZ metabolites 
(Panuwet et al., 2008). A manual mixed-polarity polymeric SPE preparation of a 2-ml urine 
sample was added to the RP-APCI-MRM analysis to determine multiple herbicides: 
phenoxyacetate ATZ; 3 chloroacetanilide herbicides acetochlor, alachlor, metochlor, and 
their mercapturates (Norrgran et al., 2006). The method achieves LODs < 1 µg/L, 
sufficiently sensitive to detect exposures in non-occupationally exposed general populations 
(Table 3). Most recently, Panuwet’s online method was expanded to create a two-
dimensional HPLC analysis that incorporates SAX and RP chromatographic separation 
modes using three multiple-port valves and three pumps (Kuklenyik et al., 2012). This 
system determines ATZ and 11 ATZ derivatives, including four mercapturates for toxicology 
and occupational exposure applications.
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Conclusions
Early HPLC mercapturate determinations were limited by non-specific ultraviolet or 
fluorometric detection techniques. Gas chromatographic techniques required cumbersome 
analyte derivitization for sensitive and specific determination of mercapturates. HPLC-MS 
now provides a powerful and useful tool for mercapturic acid quantification. HPLC-MS is a 
highly specific analysis method in which interfering or co-eluting substances found in urine 
are eliminated in the chromatographic column or are filtered from the analysis stream by ion 
selection in the mass spectrometer . Although mercapturates are often minor metabolites, 
tandem (MS/MS) offers the greatest level of analytical sensitivity for analysis, and its 
application has expanded the utility of urinary mercapturates from biomarkers of exposure to 
indicators of toxicant metabolism, biotransformation and elimination. Tandem MS analysis 
of detoxification products of minor but toxicologically significant pathways has identified 
differences in metabolism between species providing information useful in exposure risk 
assessment. Mercapturate determination has demonstrated unexpected substrate preferences 
in GSH conjugation of polycyclic aromatic hydrocarbons, and also has revealed species 
differences in the stereospecific biotransformation and detoxification of styrene. Advances 
in chromatographic techniques, such as HILIC or mixed mode have been applied to 
determination of hydroxyalkyl mercapturates of acrylamide and 1,3-butadiene to 
complement information provided by RP chromatography. The use of UHPLC has found 
application in the simultaneous mercapturate analysis, and is likely to expand as high-
pressure pumping systems become more available commercially. These applications of 
HPLC-MS/MS to the simultaneous determination of multiple mercapturates as indicators of 
exposure and metabolic processing in individuals may be expected to provide useful 
information for estimating exposure risk in both occupational and environmental health 
studies.
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Figure 1. 
Mercapturate formation begins with the conjugation of an electrophilic group (R) of a 
toxicant or toxicant metabolite with the sulfur of glutathione to form a glutathione S-
conjugate. Next glutamyl and glycine moieties are removed by transpeptidases to form a 
cysteine-S-conjugate that is N-acetylated to form a specific mercapturate. Adapted from 
Perbellini et al., 2002.
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Figure 2. 
Simplified formation of acrylamide mercapturates beginning with direct glutathione (GSH) 
conjugation to form AAMA, or by GSH conjugation of glycidamide, the electrophilic 
epoxide metabolite of acrylamide to form isomeric mercapturates GAMA2 & GAMA3. 
Asterisks (*) indicate the asymmetric carbons.
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Figure 3. 
Simplified formation of acrylonitrile mercapturates by direct detoxification to CEMA, or by 
detoxification of bioactivated cyanoethylene-epoxide to form HEMA and CHEMA.
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Figure 4. 
Metabolism of 1-bromopropane (1-BP) in the rat by multiple pathways. Direct conjugation 
of 1-BP forms n-propyl mercapturate, or 1-BP may be oxidized to form metabolites which 
are conjugated with GSH to form other mercapturates.
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Figure 5. 
Alternate pathways of 1,3 butadiene metabolism and epoxide formation produce multiple 
mercapturates: isoforms MHBMA1 and MHBMA2; DHBMA; THBMA, and bis-BDMA.
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Figure 6. 
Stereoisomeric mercapturate products of styrene side-chain oxidation. Asterisks (*) indicate 
asymmetric carbons.
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Figure 7. 
Ring oxidation of styrene produces 2,3- and 3,4-styrene oxides which may be further 
metabolized to 4-vinyl phenol and other reactive metabolites. Alternatively, the styrene 
oxides may be detoxified to produce three isomeric vinylphenol mercapturates 2-, 3- and 4-
VPMA.
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Figure 8. 
Mercapturate products of phenantherene (Phe) and benzo(a)pyrene(BP) indicate preferential 
GSH conjugation of the ‘reverse’ diol epoxides over conjugation in the bay region of 
polycyclic aromatic hydrocarbons.
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Table 1
Mercapturate abbreviation and common name by parent compound.
parent compound abbreviation N-acetyl-S-(R)-cysteine
acrylamide AAMA 2-carbamoylethylmercapturate
GAMA2 1-carbamoyl-2-hydroxyethylmercapturate
GAMA3 2-carbamoyl-2-hydroxyethylmercapturate
NASPC S-propionamidemercapturate
acrylonitrile CEMA 2-cyanoethylmercapturate
HEMA 2-hydroxyethylmercapturate
CHEMA 1-cyano-2-hydroxyethylmercapturate
acrolein 3-HPMA 3-hydroxypropylmercapturate
atrazine AZMA atrazinemercapturate
acetochlor ACMA acetochlormercapturate
alachlor ALMA alachlormercapturate
metolachlor MEMA metolachlormercapturate
benzene PMA phenylmercapturate
1-bromopropane NPMA propylmercapturate
2-bromopropane iPMA isopropylmercapturate
1,3-butadiene DHBMA 3,4-dihydroxybutylmercapturate
THBMA 2,3,4-trihydroxybutylmercapturate
bis-BDMA 2,3-dihydroxybutylmercapturate
MHBMA1 1 - hydr oxymethyl-2-propenylmercapturate
MHBMA2 2-hydroxy-3-butenylmercapturate
crotonaldehyde CPMA 3-carboxy-2-propylmercapturate
HPMMA 3-hydroxypropyl-1-methylmercapturate
dimethylacetamide AMMA acetamideomethylmercapturate
dimethylformamide AMCC methylcarbamoylmercapturate
ethylene oxide HEMA 2-hydroxyethylmercapturate
propylene oxide HPMA 2-hydroxypropylmercapturate
glycidol DHPMA 2,3-hydroxypropylmercapturate
styrene PHEMA 1-phenyl-2-hydroxyethylmercapturates
4-VPMA 4-vinylphenylmercapturate
tetrachlorethylene TCVMA trichlorovinylmercapturate
trichlorethylene 1,2-DCVMA 1,2-dichlorovinylmercapturate
2,2-DCVMA 2,2-dichlorovinylmercapturate
toluene BMA benzylmercapturate
xylene DPMA 2,4-dimethylphenylmercapturate
MBMA o-methylbenzylmercapturate
polycyclic aromatic
 hydrocarbons
  phenantherene PheO-Nac 9,10-dihydro-9-hydroxyl-10-phenanthrylmercapturate
  phenantherene
  diol epoxide
PheDE-Nac 2,3,4-trihydroxy-1,2,3,4-
tetrahydrophenanthrylmercapturate
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parent compound abbreviation N-acetyl-S-(R)-cysteine
  benzo(a)pyrene
  diol epoxide
rev-BPDE-7-Nac 8,9,10-trihydroxy-7,8,9,10-
tetrahydrobenzylmercapturate
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t a
l.,
 2
00
0
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Pa
re
n
t
co
m
po
un
d
Sa
m
pl
e
pr
ep
ar
at
io
n
C
hr
o
m
a
to
gr
ap
hy
In
te
rf
ac
e/
D
et
ec
tio
n
Ta
rg
et
m
er
ca
pt
ur
at
e
Li
m
it 
of
D
et
ec
tio
n
Va
lid
at
io
n
po
pu
la
tio
n
R
ef
er
en
ce
R
,R
-2
-
PH
B
M
A
S,
R-
2-
PH
B
M
A
R
A
M
 c
ol
um
n
sw
itc
hi
ng
R
P/
SA
X
, g
ra
di
en
t
CH
CO
O
H
/A
CN
ES
I/Q
QQ
/M
RM
−
A
ll 
PH
EM
A
s
G
en
er
al
po
pu
la
tio
n
0.
3 
μg
/L
R
es
ka
 e
t a
l.,
 2
01
0
SP
E
R
P/
SA
X
, g
ra
di
en
t
CH
CO
O
H
/C
A
N
ES
I/Q
QQ
/SR
M
−
4-
V
PM
A
H
an
d-
la
m
in
at
io
n
w
o
rk
er
s
0.
3 
μg
/L
Li
nh
ar
t e
t a
l.,
 2
01
2
ES
I: 
el
ec
tro
sp
ra
y 
io
ni
za
tio
n,
 H
IL
IC
: h
yd
ro
ph
ili
c 
in
te
ra
ct
io
n 
ch
ro
m
at
og
ra
ph
y,
 
M
R
M
: m
ul
tip
le
 re
ac
tio
n 
m
on
ito
rin
g,
 R
A
M
: r
es
tri
ct
ed
 a
cc
es
s m
ed
iu
m
, R
P:
 re
v
er
se
d 
ph
as
e,
 S
IM
: s
el
ec
te
d 
io
n 
m
on
ito
rin
g,
 S
RM
: 
se
le
ct
ed
 re
ac
tio
n 
m
on
ito
rin
g,
 S
PE
: s
ol
id
 p
ha
se
 ex
tr
ac
tio
n,
 S
Q:
 si
ng
le 
qu
ad
rup
ole
, Q
QQ
: tr
ipl
e q
ua
dru
po
le,
A
CN
: a
ce
to
ni
tri
le
, A
PC
I: 
at
m
os
ph
er
ic
 p
re
ss
ur
e 
ch
em
ic
al
 io
ni
za
tio
n,
 M
eO
H
: m
et
ha
no
l, 
RP
/W
A
X
: m
ix
ed
 m
od
e 
re
v
er
se
d 
ph
as
e-
w
ea
k 
an
io
ni
c 
in
te
ra
ct
io
n,
 R
P/
SA
X
: m
ix
ed
 m
od
e 
re
v
er
se
d 
ph
as
e-
str
on
g 
an
io
ni
c 
in
te
ra
ct
io
n,
 N
-
ac
et
yl
-c
ys
: N
-
ac
et
yl
-c
ys
te
in
e;
 P
A
H
s =
 p
ol
yc
yc
lic
 a
ro
m
at
ic
 h
yd
ro
ca
rb
on
s: 
se
e 
Ta
bl
e 
1.
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Ta
bl
e 
3
Si
m
ul
ta
ne
ou
s d
et
er
m
in
at
io
n 
of
 m
ul
tip
le
 m
er
ca
pt
ur
ic
 a
ci
ds
 b
y 
LC
/M
S.
Pa
re
n
t
co
m
po
un
ds
Sa
m
pl
e
pr
ep
ar
at
io
n
C
hr
o
m
a
to
gr
ap
hy
In
te
rf
ac
e/
D
et
ec
tio
n
Ta
rg
et
m
er
ca
pt
ur
at
e
Va
lid
at
io
n
po
pu
la
tio
n
Li
m
it 
of
D
et
ec
tio
n
R
ef
er
en
ce
m
u
lti
pl
e
de
te
rm
in
at
io
n
PA
H
’s
ph
en
an
th
er
en
e
SP
E
R
P,
 
gr
ad
ie
nt
CH
O
O
H
/A
CN
ES
I/Q
QQ
/SR
M
−
Ph
eO
-N
ac
d1
0-
Ph
eO
-N
ac
G
en
er
al
po
pu
la
tio
n
sm
o
ke
rs
 a
n
d
n
o
n
-s
m
o
ke
rs
0.
7 
ηg
/L
U
pa
dh
ya
ya
 e
t a
l.,
 2
00
6
ph
en
an
th
er
en
e
di
ol
-e
po
xi
de
Ph
eD
E-
N
ac
13
C 6
-
Ph
eD
E-
N
ac
1.
0 
ηg
/L
H
ec
ht
 e
t a
l.,
 2
00
8
be
nz
o(a
)py
re
ne
re
v
-B
PD
E-
7-
N
ac
Ph
e-
9O
H
-N
ac
1.
0 
ηg
/L
U
pa
dh
ya
ya
 e
t a
l.,
 2
01
0
m
u
lti
pl
e
de
te
rm
in
at
io
n
 
ac
ro
le
in
 
ac
ry
la
m
id
e
 
di
m
et
hy
l-
 
fo
rm
am
id
e
 
et
hy
le
ne
 o
xi
de
 
pr
op
yl
en
e 
ox
id
e
SP
E
R
P,
 
gr
ad
ie
nt
CH
O
O
H
/A
CN
ES
I/Q
QQ
/M
RM
−
3-
H
PM
A
A
A
M
A
d 4
-
A
A
M
A
A
M
CC
d 4
-
A
M
CC
H
EM
A
d 4
-
H
EM
A
2-
H
PM
A
G
en
er
al
po
pu
la
tio
n
5 
μg
/L
2.
5 
μg
/L
5 
μg
/L
0.
5 
μg
/L
5 
μg
/L
Sc
he
ttg
en
 e
t a
l.,
 2
00
8b
m
u
lti
pl
e
de
te
rm
in
at
io
n
ac
ry
lo
ni
tri
le
1,
3 
bu
ta
di
en
e
R
A
M
 p
ha
se
co
lu
m
n
sw
itc
hi
ng
R
P,
 
gr
ad
ie
nt
CH
O
O
H
/A
CN
ES
I/Q
QQ
/M
RM
−
CE
M
A
d 3
-
CE
M
A
D
H
B
M
A
d 7
-
D
H
B
M
A
M
H
B
M
A
d 6
-
M
H
B
M
A
G
en
er
al
po
pu
la
tio
n
0.
5 
μg
/L
5 
μg
/L
1 
μg
/L
Sc
he
ttg
en
 e
t a
l.,
 2
00
9
m
u
lti
pl
e
de
te
rm
in
at
io
n
ac
ry
lo
ni
tri
le
et
hy
le
ne
 o
xi
de
N
-n
itr
os
o-
 
di
m
et
hy
la
m
in
e
LL
E/
SP
E/
PF
B
B
r
de
riv
iti
za
tio
n
R
P,
 
gr
ad
ie
nt
CH
O
O
H
/A
CN
ES
I/Q
QQ
/M
RM
+
CE
M
A
d 3
-
CE
M
A
H
EM
A
d 4
-
H
EM
A
M
M
A
d 3
-
M
M
A
Sm
ok
in
g
ce
ss
at
io
n
st
ud
y
0.
2 
μg
/L
0.
3 
μg
/L
1.
4 
μg
/L
Sc
he
re
r e
t a
l.,
 2
01
0
m
u
lti
pl
e
de
te
rm
in
at
io
n
 
gl
yc
id
ol
 
et
hy
le
ne
 o
xi
de
 
pr
op
yl
en
e 
ox
id
e
 
ac
ro
le
in
 
1,
3 
bu
ta
di
en
e
SP
E
H
IL
IC
, g
ra
di
en
t
N
H
4C
H
3C
O
O
H
/A
CN
ES
I/Q
QQ
/M
RM
−
D
H
PM
A
13
C 2
-
 
D
H
PM
A
H
EM
A
d 4
-
H
EM
A
2-
H
PM
A
3-
H
PM
A
d 3
-
3-
H
PM
A
D
H
B
M
A
d 7
-
D
H
B
M
A
W
o
rk
er
s
5.
5 
μg
/L
4.
4μ
g/
L
7.
0 
μg
/L
3.
0 
μg
/L
4.
5 
μg
/L
5.
0 
μg
/L
Ec
ke
rt
 e
l a
l.,
 2
01
0
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Pa
re
n
t
co
m
po
un
ds
Sa
m
pl
e
pr
ep
ar
at
io
n
C
hr
o
m
a
to
gr
ap
hy
In
te
rf
ac
e/
D
et
ec
tio
n
Ta
rg
et
m
er
ca
pt
ur
at
e
Va
lid
at
io
n
po
pu
la
tio
n
Li
m
it 
of
D
et
ec
tio
n
R
ef
er
en
ce
M
H
B
M
A
d 6
-
M
H
B
M
A
m
u
lti
pl
e
de
te
rm
in
at
io
n
 
cr
o
to
na
ld
eh
yd
e
 
st
yr
en
e
te
tr
ac
hl
or
et
hy
le
ne
tr
ic
hl
or
et
hy
le
ne
x
yl
en
e
pr
ot
ei
n
pr
ec
ip
ita
tio
n
R
P,
 
gr
ad
ie
nt
N
H
4C
H
3C
O
O
H
/A
CN
ES
I/Q
QQ
/M
RM
−
H
PM
M
A
2 H
3-
H
PM
M
A
PH
EM
A
13
C 6
-
 
PH
EM
A
TC
V
M
A
13
C 2
-
TC
V
M
A
1,
2 
D
CV
M
A
13
C-
2 H
3 
1,
2-
D
CV
M
A
2,
2 
D
CV
M
A
13
C-
2 H
3 
2,
2-
D
CV
M
A
D
PM
A
2 H
3-
D
PM
A
G
en
er
al
po
pu
la
tio
n
1.
3 
μg
/L
0.
7 
μg
/L
3.
0 
μg
/L
12
.6
 μ
g/
L
6.
5 
μg
/L
5.
0 
μg
/L
A
lw
is 
et
 a
l.,
 2
01
2
m
u
lti
pl
e
de
te
rm
in
at
io
n
 
be
nz
en
e
 
to
lu
en
e
 
x
yl
en
e
SP
E
R
P,
 
gr
ad
ie
nt
CH
3C
O
O
H
/M
eO
H
ES
I/Q
QQ
/M
RM
−
PM
A
d 5
-
PM
A
B
M
A
d 5
-
B
M
A
M
B
M
A
2-
H
PM
A
U
rb
an
 tr
af
fic
w
ar
de
ns
0.
30
 μ
g/
L
0.
35
 μ
g/
L
0.
40
 μ
g/
L
Sa
ba
tin
i e
l a
l.,
 2
00
8
m
u
lti
pl
e
de
te
rm
in
at
io
n
 
at
ra
zi
ne
 
ac
et
oc
hl
or
 
al
ac
hl
or
 
m
et
ol
ac
hl
or
SP
E
R
P,
 
gr
ad
ie
nt
CH
3C
O
O
H
/A
CN
A
PC
I/Q
QQ
/M
RM
−
A
ZM
A
13
C 3
-
A
ZM
A
A
CM
A
13
C 6
-
A
CM
A
A
LM
A
13
C 6
-
A
LM
A
M
EM
A
13
C 6
-
M
EM
A
M
en
 in
 a
ru
ra
l a
gr
ar
ia
n
re
gi
on
60
 η
g/
L
48
 η
g/
L
39
 η
g/
L
36
 η
g/
L
N
or
rg
ra
n 
et
 a
l.,
 2
00
6
A
CN
: a
ce
to
ni
tri
le
, A
PC
I: 
at
m
os
ph
er
ic
 p
re
ss
ur
e 
ch
em
ic
al
 io
ni
za
tio
n,
 E
SI
: e
le
ct
ro
sp
ra
y 
io
ni
za
tio
n,
 H
IL
IC
: h
yd
ro
ph
ili
c 
in
te
ra
ct
io
n 
ch
ro
m
at
og
ra
ph
y,
 
M
eO
H
: m
et
ha
no
l, 
M
RM
: m
ul
tip
le
 re
ac
tio
n 
m
on
ito
rin
g,
 N
-
ac
et
yl
-c
ys
: N
-
ac
et
yl
-c
ys
te
in
e,
 P
FB
Br
: p
en
ta
flu
or
ob
en
zy
l b
ro
m
id
e,
 R
P:
 re
v
er
se
d 
ph
as
e,
 R
P-
W
A
X
: m
ix
ed
 m
od
e 
re
v
er
se
d 
ph
as
e-
w
ea
k 
an
io
ni
c 
in
te
ra
ct
io
n,
 S
PE
: s
ol
id
 p
ha
se
 ex
tr
ac
tio
n,
 Q
QQ
: tr
ipl
e q
ua
dru
po
le
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